Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E-Mart | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩2.4T | -4x | 0.01 | ₩89,600 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.2% Upside | Upgrade to Pro+ | |
BGF Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩2.09T | 11.7x | -3.4 | ₩121,200 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.5% Upside | Upgrade to Pro+ | |
Gs Retail | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩1.44T | -27x | 0.17 | ₩17,200 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.1% Downside | Upgrade to Pro+ | |
Hyundai Green Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩557.55B | 7.9x | 0.34 | ₩16,930 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -61% Downside | Upgrade to Pro+ | |
SPC Samlip | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩445.79B | 5.1x | 0.07 | ₩55,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CJ Freshway | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩356.15B | 16x | -0.24 | ₩30,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.7% Upside | Upgrade to Pro+ | |
Curexo | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩354.2B | -15.6x | ₩8,620 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Kyochon | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩255.32B | 533.2x | -5.05 | ₩5,110 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinsegae Food | Seoul | Consumer Non-Cyclicals | Food & Drug Retailing | ₩145.6B | 11.9x | -0.91 | ₩37,600 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33% Upside | Upgrade to Pro+ | |
Seouleaguer | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩93.31B | 18.5x | 0.28 | ₩1,078 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boratr | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩62.81B | 10.6x | -0.31 | ₩9,590 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KBio Company | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩33.15B | -4.3x | -0.11 | ₩287 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CuroHoldings | KOSDAQ | Consumer Non-Cyclicals | Food & Drug Retailing | ₩18.19B | -0.7x | 0.03 | ₩785 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |